Systematic Review and Meta-Analysis of SERPINE1 4G/5G Insertion/Deletion Variant With Circulating Lipid Levels
Recent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD....
Saved in:
Published in | Frontiers in cardiovascular medicine Vol. 9; p. 859979 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
23.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD.BackgroundRecent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD.By searching PubMed and the Cochrane databases for studies published before 31 October 2021, 40 studies conducted on a total of 13,117 subjects were included for the analysis. The consistent findings for the effects of the 5G allele of rs1799889 variant on lipid metabolism were the significantly decreased triglycerides (TG) [standardized mean difference (SMD) = -0.12, 95% CI = -0.21 to 0.03, P = 0.01], total cholesterol (TC) (SMD = -0.12, 95% CI = -0.17 to 0.06, P < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = -0.13, 95% CI = -0.23 to 0.03, P = 0.01) levels. Intriguingly, the significant effects of the rs1799889 variant on LDL-C (SMD = -0.15, 95% CI = -0.26 to 0.05, P < 0.01) and TC (SMD = -0.17, 95% CI = -0.27 to 0.07, P < 0.01) levels were primarily observed in the Asian population. However, the significant effect of the rs1799889 variant on high-density lipoprotein cholesterol (HDL-C) (SMD = 0.26, 95% CI = 0.03-0.48, P = 0.03) levels was detected only in female subjects.Methods and ResultsBy searching PubMed and the Cochrane databases for studies published before 31 October 2021, 40 studies conducted on a total of 13,117 subjects were included for the analysis. The consistent findings for the effects of the 5G allele of rs1799889 variant on lipid metabolism were the significantly decreased triglycerides (TG) [standardized mean difference (SMD) = -0.12, 95% CI = -0.21 to 0.03, P = 0.01], total cholesterol (TC) (SMD = -0.12, 95% CI = -0.17 to 0.06, P < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = -0.13, 95% CI = -0.23 to 0.03, P = 0.01) levels. Intriguingly, the significant effects of the rs1799889 variant on LDL-C (SMD = -0.15, 95% CI = -0.26 to 0.05, P < 0.01) and TC (SMD = -0.17, 95% CI = -0.27 to 0.07, P < 0.01) levels were primarily observed in the Asian population. However, the significant effect of the rs1799889 variant on high-density lipoprotein cholesterol (HDL-C) (SMD = 0.26, 95% CI = 0.03-0.48, P = 0.03) levels was detected only in female subjects.The rs1799889 variant of SERPINE1 is a protective genetic factor against CAD, the Asian population with the 5G allele of the rs1799889 variant may have a reduced CAD risk.ConclusionThe rs1799889 variant of SERPINE1 is a protective genetic factor against CAD, the Asian population with the 5G allele of the rs1799889 variant may have a reduced CAD risk. |
---|---|
AbstractList | BackgroundRecent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD.Methods and ResultsBy searching PubMed and the Cochrane databases for studies published before 31 October 2021, 40 studies conducted on a total of 13,117 subjects were included for the analysis. The consistent findings for the effects of the 5G allele of rs1799889 variant on lipid metabolism were the significantly decreased triglycerides (TG) [standardized mean difference (SMD) = –0.12, 95% CI = –0.21 to 0.03, P = 0.01], total cholesterol (TC) (SMD = –0.12, 95% CI = –0.17 to 0.06, P < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = –0.13, 95% CI = –0.23 to 0.03, P = 0.01) levels. Intriguingly, the significant effects of the rs1799889 variant on LDL-C (SMD = –0.15, 95% CI = –0.26 to 0.05, P < 0.01) and TC (SMD = –0.17, 95% CI = –0.27 to 0.07, P < 0.01) levels were primarily observed in the Asian population. However, the significant effect of the rs1799889 variant on high-density lipoprotein cholesterol (HDL-C) (SMD = 0.26, 95% CI = 0.03–0.48, P = 0.03) levels was detected only in female subjects.ConclusionThe rs1799889 variant of SERPINE1 is a protective genetic factor against CAD, the Asian population with the 5G allele of the rs1799889 variant may have a reduced CAD risk. Recent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD.BackgroundRecent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD.By searching PubMed and the Cochrane databases for studies published before 31 October 2021, 40 studies conducted on a total of 13,117 subjects were included for the analysis. The consistent findings for the effects of the 5G allele of rs1799889 variant on lipid metabolism were the significantly decreased triglycerides (TG) [standardized mean difference (SMD) = -0.12, 95% CI = -0.21 to 0.03, P = 0.01], total cholesterol (TC) (SMD = -0.12, 95% CI = -0.17 to 0.06, P < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = -0.13, 95% CI = -0.23 to 0.03, P = 0.01) levels. Intriguingly, the significant effects of the rs1799889 variant on LDL-C (SMD = -0.15, 95% CI = -0.26 to 0.05, P < 0.01) and TC (SMD = -0.17, 95% CI = -0.27 to 0.07, P < 0.01) levels were primarily observed in the Asian population. However, the significant effect of the rs1799889 variant on high-density lipoprotein cholesterol (HDL-C) (SMD = 0.26, 95% CI = 0.03-0.48, P = 0.03) levels was detected only in female subjects.Methods and ResultsBy searching PubMed and the Cochrane databases for studies published before 31 October 2021, 40 studies conducted on a total of 13,117 subjects were included for the analysis. The consistent findings for the effects of the 5G allele of rs1799889 variant on lipid metabolism were the significantly decreased triglycerides (TG) [standardized mean difference (SMD) = -0.12, 95% CI = -0.21 to 0.03, P = 0.01], total cholesterol (TC) (SMD = -0.12, 95% CI = -0.17 to 0.06, P < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = -0.13, 95% CI = -0.23 to 0.03, P = 0.01) levels. Intriguingly, the significant effects of the rs1799889 variant on LDL-C (SMD = -0.15, 95% CI = -0.26 to 0.05, P < 0.01) and TC (SMD = -0.17, 95% CI = -0.27 to 0.07, P < 0.01) levels were primarily observed in the Asian population. However, the significant effect of the rs1799889 variant on high-density lipoprotein cholesterol (HDL-C) (SMD = 0.26, 95% CI = 0.03-0.48, P = 0.03) levels was detected only in female subjects.The rs1799889 variant of SERPINE1 is a protective genetic factor against CAD, the Asian population with the 5G allele of the rs1799889 variant may have a reduced CAD risk.ConclusionThe rs1799889 variant of SERPINE1 is a protective genetic factor against CAD, the Asian population with the 5G allele of the rs1799889 variant may have a reduced CAD risk. |
Author | Peng, Yuanyuan Li, Hang Zhou, Yawen Lin, Xuan Luo, Zhi Fang, Ying Liu, Yang Wan, Jing Wei, Baozhu |
AuthorAffiliation | 1 Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan University , Wuhan , China 3 Department of Geratology, Zhongnan Hospital of Wuhan University, Wuhan University , Wuhan , China 4 Institute of Myocardial Injury and Repair, Wuhan University , Wuhan , China 2 Department of Endocrinology, China Resources and WISCO General Hospital , Wuhan , China |
AuthorAffiliation_xml | – name: 2 Department of Endocrinology, China Resources and WISCO General Hospital , Wuhan , China – name: 4 Institute of Myocardial Injury and Repair, Wuhan University , Wuhan , China – name: 1 Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan University , Wuhan , China – name: 3 Department of Geratology, Zhongnan Hospital of Wuhan University, Wuhan University , Wuhan , China |
Author_xml | – sequence: 1 givenname: Zhi surname: Luo fullname: Luo, Zhi – sequence: 2 givenname: Yang surname: Liu fullname: Liu, Yang – sequence: 3 givenname: Hang surname: Li fullname: Li, Hang – sequence: 4 givenname: Yawen surname: Zhou fullname: Zhou, Yawen – sequence: 5 givenname: Yuanyuan surname: Peng fullname: Peng, Yuanyuan – sequence: 6 givenname: Xuan surname: Lin fullname: Lin, Xuan – sequence: 7 givenname: Ying surname: Fang fullname: Fang, Ying – sequence: 8 givenname: Jing surname: Wan fullname: Wan, Jing – sequence: 9 givenname: Baozhu surname: Wei fullname: Wei, Baozhu |
BookMark | eNp1kU1vEzEQhi1UREvpnaOPXDaxvWuvfUGqQgiRwodavm6W1zubuvLawd4E5d-zS4pEkTjNaGbeZ0bzPkdnIQZA6CUls7KUat7ZQz9jhLGZ5ErV6gm6YEzVBeH8-9lf-Tm6yvmeEEJ5JbmQz9B5ySWlNSUXKNwe8wC9GZzFN3Bw8BOb0OL3MJjiOhh_zC7j2OHb5c2n9YclxdVqzld4HTKkwcUwfwMepgR_NcmZMOBvbrjDC5fs3o_UsMUbt3Mt3sABfH6BnnbGZ7h6iJfoy9vl58W7YvNxtV5cbwpblWooGguWdURSYhRXQijGm5JZA1XbKVC0JqU13DLoGAepJJfEtlQqoxrLoWnLS7Q-cdto7vUuud6ko47G6d-FmLbajPdbD7prBIxrRFNyqGrBDGPc1lJU3fQyQUbW6xNrt296aC2EIRn_CPq4E9yd3saDVkwQSsoR8OoBkOKPPeRB9y5b8N4EiPusmZCSSMElG0fFadSmmHOCTls3mOm_I9l5TYmevNeT93ryXp-8H4XkH-Gf-_4r-QWnprM8 |
CitedBy_id | crossref_primary_10_1002_advs_202412578 crossref_primary_10_3390_genes16020223 crossref_primary_10_1016_j_heliyon_2024_e35426 crossref_primary_10_1371_journal_pone_0317511 |
Cites_doi | 10.1248/bpb.b20-00321 10.3390/ijms19041197 10.1038/s41598-020-79948-x 10.1007/s00063-006-1090-0 10.1515/cclm-2013-1124 10.1016/j.thromres.2012.06.015 10.3164/jcbn.11-48 10.1161/circ.106.25.3143 10.14712/fb2020066050169 10.1371/journal.pone.0033511 10.2337/db12-1552 10.1210/en.2013-1888 10.1081/erc-200035728 10.1038/sj.emboj.7601082 10.1093/eurheartj/ehz455 10.1074/jbc.273.11.6358 10.1016/0925-4773(96)00515-1 10.1161/01.atv.11.1.183 10.3389/fgene.2021.746686 10.1182/blood.V92.9.3277 10.1016/j.jclinepi.2009.06.006 10.1007/s11239-009-0398-z 10.1007/s00508-005-0425-9 10.1080/21623945.2020.1748961 10.1371/journal.pone.0079150 10.1073/pnas.92.6.1851 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei. Copyright © 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei. 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei |
Copyright_xml | – notice: Copyright © 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei. – notice: Copyright © 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei. 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fcvm.2022.859979 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2297-055X |
ExternalDocumentID | oai_doaj_org_article_fb6e0a96b35e4762a225c7864f000160 PMC9260103 10_3389_fcvm_2022_859979 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAYXX ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV CITATION GROUPED_DOAJ HYE KQ8 M48 M~E OK1 PGMZT RPM 7X8 5PM |
ID | FETCH-LOGICAL-c439t-bcec2f0810a95966925b32cae4df9e91703ca5c2ef25e898580cd189a9bc5ebd3 |
IEDL.DBID | M48 |
ISSN | 2297-055X |
IngestDate | Wed Aug 27 01:10:44 EDT 2025 Thu Aug 21 18:08:21 EDT 2025 Fri Jul 11 09:35:53 EDT 2025 Thu Apr 24 22:57:52 EDT 2025 Tue Jul 01 01:10:16 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c439t-bcec2f0810a95966925b32cae4df9e91703ca5c2ef25e898580cd189a9bc5ebd3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 Edited by: Neil Morgan, University of Birmingham, United Kingdom Reviewed by: Guangyu Zhang, City of Hope National Medical Center, United States; Yingfeng Wan, University of Michigan, United States These authors have contributed equally to this work and share first authorship This article was submitted to Cardiovascular Genetics and Systems Medicine, a section of the journal Frontiers in Cardiovascular Medicine |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fcvm.2022.859979 |
PMID | 35811710 |
PQID | 2688086582 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_fb6e0a96b35e4762a225c7864f000160 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9260103 proquest_miscellaneous_2688086582 crossref_citationtrail_10_3389_fcvm_2022_859979 crossref_primary_10_3389_fcvm_2022_859979 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-06-23 |
PublicationDateYYYYMMDD | 2022-06-23 |
PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-23 day: 23 |
PublicationDecade | 2020 |
PublicationTitle | Frontiers in cardiovascular medicine |
PublicationYear | 2022 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Tamura (B4) 2014; 155 Vash (B23) 1998; 92 Botta (B21) 2018; 19 Liu (B5) 2020; 9 Li (B29) 2012; 7 Cao (B24) 2006; 25 Rallidis (B16) 2010; 29 Tamura (B3) 2013; 62 Liu (B12) 2021; 12 Liberati (B11) 2009; 62 Xu (B10) 2013; 8 Stefansson (B22) 1998; 273 Eriksson (B2) 1995; 92 Liang (B9) 2015; 8 Funk (B13) 2005; 117 (B28) 2002; 106 Grundy (B26) 2019; 139 de la Cruz-Mosso (B17) 2016; 57 Mach (B27) 2020; 41 Yoda (B20) 2020; 43 Zietz (B19) 2006; 101 Gong (B8) 2012; 130 Zietz (B18) 2004; 30 Teesalu (B25) 1996; 56 Levine (B6) 2021; 11 Dawson (B1) 1991; 11 Nikolopoulos (B7) 2014; 52 Mahmutbegovic (B14) 2020; 66 Al-Hamodi (B15) 2012; 50 |
References_xml | – volume: 57 start-page: 246 year: 2016 ident: B17 article-title: PAI-1 haplogenotype confers genetic susceptibility for obesity and hypertriglyceridemia in Mexican children. publication-title: Invest Clin. – volume: 43 start-page: 1375 year: 2020 ident: B20 article-title: Gene Deletion of calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) suppresses adipogenic differentiation of mouse embryonic fibroblasts. publication-title: Biol Pharm Bull. doi: 10.1248/bpb.b20-00321 – volume: 19 year: 2018 ident: B21 article-title: PPAR agonists and metabolic syndrome: an established role? publication-title: Int J Mol Sci. doi: 10.3390/ijms19041197 – volume: 11 year: 2021 ident: B6 article-title: Role of PAI-1 in hepatic steatosis and dyslipidemia. publication-title: Sci Rep. doi: 10.1038/s41598-020-79948-x – volume: 101 start-page: 605 year: 2006 ident: B19 article-title: Kandidatengene des diabetes mellitus typ 2 Gibt es einen Gen-Dosiseffekt für Risikofaktoren sowie mikro-und makrovaskuläre Folgeerkrankungen? publication-title: Med Klin (Munich). doi: 10.1007/s00063-006-1090-0 – volume: 52 start-page: 937 year: 2014 ident: B7 article-title: The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis. publication-title: Clin Chem Lab Med. doi: 10.1515/cclm-2013-1124 – volume: 139 start-page: e1082 year: 2019 ident: B26 article-title: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. publication-title: Circulation. – volume: 130 start-page: e43 year: 2012 ident: B8 article-title: Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis. publication-title: Thromb Res. doi: 10.1016/j.thromres.2012.06.015 – volume: 50 start-page: 184 year: 2012 ident: B15 article-title: Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects. publication-title: J Clin Biochem Nutr. doi: 10.3164/jcbn.11-48 – volume: 106 start-page: 3143 year: 2002 ident: B28 article-title: Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. publication-title: Circulation. doi: 10.1161/circ.106.25.3143 – volume: 66 start-page: 169 year: 2020 ident: B14 article-title: Bosnian study on markers of ischaemic stroke in adults 20-50 years old (SMISAO): preliminary report. publication-title: Folia Biol (Praha). doi: 10.14712/fb2020066050169 – volume: 7 year: 2012 ident: B29 article-title: Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis. publication-title: PLoS One. doi: 10.1371/journal.pone.0033511 – volume: 62 start-page: 3170 year: 2013 ident: B3 article-title: Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice. publication-title: Diabetes. doi: 10.2337/db12-1552 – volume: 155 start-page: 1708 year: 2014 ident: B4 article-title: Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice. publication-title: Endocrinology. doi: 10.1210/en.2013-1888 – volume: 30 start-page: 443 year: 2004 ident: B18 article-title: Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels. publication-title: Endocr Res. doi: 10.1081/erc-200035728 – volume: 25 start-page: 1860 year: 2006 ident: B24 article-title: Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. publication-title: EMBO J. doi: 10.1038/sj.emboj.7601082 – volume: 41 start-page: 111 year: 2020 ident: B27 article-title: 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. publication-title: Eur Heart J. doi: 10.1093/eurheartj/ehz455 – volume: 273 start-page: 6358 year: 1998 ident: B22 article-title: Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein. publication-title: J Biol Chem. doi: 10.1074/jbc.273.11.6358 – volume: 56 start-page: 103 year: 1996 ident: B25 article-title: Embryo implantation in mouse: fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha 2MR/LRP genes. publication-title: Mech Dev. doi: 10.1016/0925-4773(96)00515-1 – volume: 11 start-page: 183 year: 1991 ident: B1 article-title: Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. publication-title: Arterioscler Thromb. doi: 10.1161/01.atv.11.1.183 – volume: 8 start-page: 2097 year: 2015 ident: B9 article-title: PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis. publication-title: Int J Clin Exp Med. – volume: 12 year: 2021 ident: B12 article-title: Associations of the miRNA-146a rs2910164 and the miRNA-499a rs3746444 polymorphisms with plasma lipid levels: a meta-analysis. publication-title: Front Genet. doi: 10.3389/fgene.2021.746686 – volume: 92 start-page: 3277 year: 1998 ident: B23 article-title: Three complement-type repeats of the low-density lipoprotein receptor-related protein define a common binding site for RAP, PAI-1, and lactoferrin. publication-title: Blood. doi: 10.1182/blood.V92.9.3277 – volume: 62 start-page: e1 year: 2009 ident: B11 article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. publication-title: J Clin Epidemiol. doi: 10.1016/j.jclinepi.2009.06.006 – volume: 29 start-page: 497 year: 2010 ident: B16 article-title: Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction. publication-title: J Thromb Thrombolysis. doi: 10.1007/s11239-009-0398-z – volume: 117 start-page: 707 year: 2005 ident: B13 article-title: PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus. publication-title: Wien Klin Wochenschr. doi: 10.1007/s00508-005-0425-9 – volume: 9 start-page: 170 year: 2020 ident: B5 article-title: Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity. publication-title: Adipocyte. doi: 10.1080/21623945.2020.1748961 – volume: 8 year: 2013 ident: B10 article-title: PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study. publication-title: PLoS One. doi: 10.1371/journal.pone.0079150 – volume: 92 start-page: 1851 year: 1995 ident: B2 article-title: Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. publication-title: Proc Natl Acad Sci USA. doi: 10.1073/pnas.92.6.1851 |
SSID | ssj0001548568 |
Score | 2.2351167 |
SecondaryResourceType | review_article |
Snippet | Recent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims... BackgroundRecent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 859979 |
SubjectTerms | Asian Cardiovascular Medicine coronary artery disease lipid polymorphism rs1799889 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Rb9MwELbQHiZeEAwQhYE8iRceQlo7TuxH2LoVRHlgDPpmOWd7q4Tcqc32-7lL0qp5YS88RUocJb475-7Lnb9j7D34qlAQZSahihlRnmcm-oALzztQiD_CmPYOz7-Xs6vi60It9lp9UU1YRw_cCS6PNQ03ZS1VKHDlOjRAqHRZxDZcadE6-rw9MNXtDy60KnWXl0QUZvII97TxXIiPWhlDlVt7fqil6x_EmMMKyT2Xc_6UPeljRf6pe8dn7FFIR-xw3mfDn7N0uaNh5t0_fu6S5_PQuGxLNsJXkV9OfyB4n054cZGrC_4lUQYe9ZGfBaLeXiX-CxEzipj_XjY3_HS5hrapV7rm1Nra829UWbR5wa7Opz9PZ1nfPyEDDDOarIYAIqLPR_kphDVGqFoKcKHw0QTEaWMJToEIUaigjVZ6DH6ijTM1qFB7-ZIdpFUKrxivXKzaaKXyvgB0YW4ig8dYEuNNPPgRy7fStNCTi1OPiz8WQQbJ35L8LcnfdvIfsQ-7O247Yo1_jP1MCtqNI0rs9gQaiu0NxT5kKCN2slWvxSVEeRGXwupuY0WJHzGNkxMjVg30Pnji8Epa3rRk3IY42cby9f94xTfsMc2aKtGEPGYHzfouvMWYp6nfteb9F3yR_x4 priority: 102 providerName: Directory of Open Access Journals |
Title | Systematic Review and Meta-Analysis of SERPINE1 4G/5G Insertion/Deletion Variant With Circulating Lipid Levels |
URI | https://www.proquest.com/docview/2688086582 https://pubmed.ncbi.nlm.nih.gov/PMC9260103 https://doaj.org/article/fb6e0a96b35e4762a225c7864f000160 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBZpAqWX0ifdvFChlx6c9UrWyjqEkqabR-n20HTbvQlZj2QhyM2uU5p_nxnbu40hhJwMfshoxqP5xqP5hpAP1slM2MATbmVIkPI8UcF5MDxnrID4w6dYOzz-PjyZZF-nYvq_PLoV4OLe0A77SU3ml3v_rm4-gcHvY8QJ_rYf7F-sKWdsLxdKSfWEbIBfkmim4xbsNzXDWd7UxjGGFKRCTJu85b2DdPxUTeffwaDdHZR3XNLRC_K8xZL0oFH-S7Lm4yvydNxmy1-TeLaiaaZNDoCa6OjYVyZZkpHQMtCz0Q8I7kcDmh33xTE9jZihB331v3ik5i4j_QURNaiA_p5VF_RwNrd10694TrH1taPfcOfR4g2ZHI1-Hp4kbX-FxAIMqZLCessCYILUKAFhj2Ki4Mwan7mgPMRxKbdGWOYDEz5XuchT6wa5MqqwwheOvyXrsYz-HaHSBFmjGelcZsHFmQH3DrAm4FE4uB7pL6WpbUs-jj0wLjUEISh_jfLXKH_dyL9HPq6e-NMQbzxw72dU0Oo-pMyuT5Tzc91aoA4FfndqWHDhM3ABBlYyK_NhFmrcm_bI-6V6NZgY5k1M9OX1QrMhLHI5TI71iOzovfPG7pU4u6jJuhVytqV88xGjb5FnOCnciMb4Nlmv5td-ByBPVezWvwp26-_5Fo2MAFs |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systematic+Review+and+Meta-Analysis+of+SERPINE1+4G%2F5G+Insertion%2FDeletion+Variant+With+Circulating+Lipid+Levels&rft.jtitle=Frontiers+in+cardiovascular+medicine&rft.au=Luo%2C+Zhi&rft.au=Liu%2C+Yang&rft.au=Li%2C+Hang&rft.au=Zhou%2C+Yawen&rft.date=2022-06-23&rft.issn=2297-055X&rft.eissn=2297-055X&rft.volume=9&rft.spage=859979&rft_id=info:doi/10.3389%2Ffcvm.2022.859979&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2297-055X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2297-055X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2297-055X&client=summon |